Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients With Advanced Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Fluorouracil
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 20 Oct 2016 Status changed from active, no longer recruiting to completed.
- 10 Feb 2016 Planned End Date changed from 1 Feb 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 10 Feb 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.